These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17082574)

  • 1. Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells.
    Radcliffe JN; Roddick JS; Friedmann PS; Stevenson FK; Thirdborough SM
    J Immunol; 2006 Nov; 177(10):6626-33. PubMed ID: 17082574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
    Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
    J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
    Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D
    J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptides.
    Schirmbeck R; Fissolo N; Chaplin P; Reimann J
    J Immunol; 2003 Aug; 171(3):1240-6. PubMed ID: 12874211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
    Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J
    J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways.
    Rush C; Mitchell T; Garside P
    J Immunol; 2002 Nov; 169(9):4951-60. PubMed ID: 12391208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
    Schlecht G; Loucka J; Najar H; Sebo P; Leclerc C
    J Immunol; 2004 Nov; 173(10):6089-97. PubMed ID: 15528345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.
    Norbury CC; Princiotta MF; Bacik I; Brutkiewicz RR; Wood P; Elliott T; Bennink JR; Yewdell JW
    J Immunol; 2001 Apr; 166(7):4355-62. PubMed ID: 11254689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
    Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
    J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization.
    Nagata T; Higashi T; Aoshi T; Suzuki M; Uchijima M; Koide Y
    Vaccine; 2001 Oct; 20(1-2):105-14. PubMed ID: 11567753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines.
    Rice J; Elliott T; Buchan S; Stevenson FK
    J Immunol; 2001 Aug; 167(3):1558-65. PubMed ID: 11466377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.
    Storni T; Bachmann MF
    J Immunol; 2004 May; 172(10):6129-35. PubMed ID: 15128799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal.
    Boisgérault F; Rueda P; Sun CM; Hervas-Stubbs S; Rojas M; Leclerc C
    J Immunol; 2005 Mar; 174(6):3432-9. PubMed ID: 15749877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
    Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection.
    Pope C; Kim SK; Marzo A; Masopust D; Williams K; Jiang J; Shen H; Lefrançois L
    J Immunol; 2001 Mar; 166(5):3402-9. PubMed ID: 11207297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.